The global pharmaceutical industry experienced a 7% rise in new job postings related to artificial intelligence in Q3 2022 compared with the previous quarter, according to GlobalData’s whitepaper on Artificial Intelligence in Pharmaceutical – Hiring Activity in Q3 2022. This compares to a 63% increase versus Q3 2021.
Notably, General and Operations Managers jobs accounted for an 11% share of the global pharmaceutical industry’s artificial intelligence-related total new job postings in Q3 2022, up 12% over the prior quarter.
General and Operations Managers, with a share of 11%, emerged as the top artificial intelligence-related job roles within the pharmaceutical industry in Q3 2022, with new job postings rising by 12% quarter-on-quarter. Software and Web Developers, Programmers, and Testers came in second with a share of 8% in Q3 2022, with new job postings dropping by 2% over the previous quarter.
The other prominent artificial intelligence roles include Data Scientists with an 8% share in Q3 2022, Biological Scientists with a 6% share of new job postings.
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q3 2022 were Johnson & Johnson, Evolent Health, GSK and Intermountain Healthcare. Together they accounted for a combined share of 14% of all artificial intelligence-related active jobs in the pharmaceutical industry.
Johnson & Johnson posted 705 jobs in Q3 2022 and registered a drop of 7% over the previous quarter, followed by Evolent Health with 610 jobs and a 34% growth. GSK with 328 jobs and Intermountain Healthcare with 305 jobs, recorded a 18% growth and a 78% increase, respectively, while CVS Health recorded a 6% decline with 297 job postings during Q3 2022.
The largest share of artificial intelligence-related new job postings in the pharmaceutical industry in Q3 2022 was in the US with 73% followed by the UK (5%) and India (3%). The share represented by the US was three percentage points higher than the 70% share it accounted for in Q2 2022.